Stocks
MAIA Biotechnology, Inc.MAIA
AMEXHealthcareBiotechnology$1.08
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted cancer therapies, with its lead candidate THIO being evaluated in clinical trials for non-small cell lung cancer. The company focuses on telomere-targeting agents that aim to induce cancer cell death while sparing healthy tissue. Investors track MAIA for its oncology pipeline and upcoming clinical data readouts.
52W Range: $0.87-$3.19
Congressional Interest in MAIA Biotechnology, Inc. (MAIA)
No congressional trades have been disclosed for MAIA Biotechnology, Inc. (MAIA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MAIA?
No congressional trades found for this stock.